These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 30682328

  • 21. BRAFV600E mutation test on fine-needle aspiration specimens of thyroid nodules: Clinical correlations for 4600 patients.
    Chen H, Song A, Wang Y, He Y, Tong J, Di J, Li C, Zhou Z, Cai X, Zhong D, Da J.
    Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
    [Abstract] [Full Text] [Related]

  • 22. Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis.
    Fnais N, Soobiah C, Al-Qahtani K, Hamid JS, Perrier L, Straus SE, Tricco AC.
    Hum Pathol; 2015 Oct; 46(10):1443-54. PubMed ID: 26232865
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules.
    Beiša A, Kvietkauskas M, Beiša V, Stoškus M, Ostanevičiūtė E, Jasiūnas E, Griškevičius L, Šeinin D, Šileikytė A, Strupas K.
    Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):247-254. PubMed ID: 29566402
    [Abstract] [Full Text] [Related]

  • 25. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.
    Paek SH, Kim BS, Kang KH, Kim HS.
    World J Surg Oncol; 2017 Nov 13; 15(1):202. PubMed ID: 29132392
    [Abstract] [Full Text] [Related]

  • 26. Are there specific cytologic features that can predict BRAFV600E mutational status of papillary thyroid carcinoma in fine-needle aspiration specimens?
    Mendes JM, Elsheikh TM, Di Marco J, Russell J, Gladkaya T, Nicolas MM, Clapacs E, Bena JF, McAfee JL, Policarpio-Nicolas MLC.
    Diagn Cytopathol; 2024 Jun 13; 52(6):295-302. PubMed ID: 38372437
    [Abstract] [Full Text] [Related]

  • 27. [The predictive accuracy of fine needle aspiration and BRAF V600E mutation in diagnosis of papillary thyroid carcinoma].
    Yu X, Wang Y, Xie QP, Yan HC, Zhao QZ, Zhang ML, Xiang C, Wang P.
    Zhonghua Wai Ke Za Zhi; 2019 Apr 01; 57(4):305-308. PubMed ID: 30929378
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. BRAFv600e mutation combined with thyroglobulin and fine-needle aspiration in diagnosis of lymph node metastasis of papillary thyroid carcinoma.
    Li J, Liu J, Yu X, Bao X, Qian L.
    Pathol Res Pract; 2018 Nov 01; 214(11):1892-1897. PubMed ID: 30270103
    [Abstract] [Full Text] [Related]

  • 30. BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.
    Zatelli MC, Trasforini G, Leoni S, Frigato G, Buratto M, Tagliati F, Rossi R, Cavazzini L, Roti E, degli Uberti EC.
    Eur J Endocrinol; 2009 Sep 01; 161(3):467-73. PubMed ID: 19574281
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Analysis of BRAF(V600E) mutation and DNA methylation improves the diagnostics of thyroid fine needle aspiration biopsies.
    Zhang B, Liu S, Zhang Z, Wei J, Qu Y, Wu K, Yang Q, Hou P, Shi B.
    Diagn Pathol; 2014 Mar 03; 9():45. PubMed ID: 24588959
    [Abstract] [Full Text] [Related]

  • 34. The Role of BRAF V600E in Reducing AUS/FLUS Diagnosis in Thyroid Fine Needle Aspiration.
    Yin L, Tang Y, Yu S, Wang C, Xiao M, Wang Y, Liu SJ, Gao L, Huang K, Jin L.
    Endocr Pathol; 2019 Dec 03; 30(4):312-317. PubMed ID: 31529211
    [Abstract] [Full Text] [Related]

  • 35. Detection of BRAF V600E in Fine-Needle Aspiration Samples of Thyroid Nodules by Droplet Digital PCR.
    Lu SY, Chen YC, Feng JL, Zhou QY, Chen J, Zhu CF, Guo MM, Zhang MM, Zhang QY, Lu M, Yang L, Wu J, Zhao SX, Song HD, Ye XP.
    Int J Endocrinol; 2022 Dec 03; 2022():6243696. PubMed ID: 35392249
    [Abstract] [Full Text] [Related]

  • 36. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
    Zimmermann AK, Camenisch U, Rechsteiner MP, Bode-Lesniewska B, Rössle M.
    Cancer Cytopathol; 2014 Jan 03; 122(1):48-58. PubMed ID: 24039206
    [Abstract] [Full Text] [Related]

  • 37. BRAFV600E mutation in fine-needle aspiration aspirates: Association with poorer prognostic factors in larger papillary thyroid carcinomas.
    Lee JI, Jang HW, Kim SW, Kim JW, Oh YL, Chung JH.
    Head Neck; 2013 Apr 03; 35(4):548-53. PubMed ID: 22488961
    [Abstract] [Full Text] [Related]

  • 38. Circulating Tumor DNA Harboring the BRAFV600E Mutation May Predict Poor Outcomes of Primary Papillary Thyroid Cancer Patients.
    Sato A, Tanabe M, Tsuboi Y, Niwa T, Shinozaki-Ushiku A, Seto Y, Murakami Y.
    Thyroid; 2021 Dec 03; 31(12):1822-1828. PubMed ID: 34541884
    [Abstract] [Full Text] [Related]

  • 39. Immunohistochemistry is highly sensitive and specific for detecting the BRAF V600E mutation in papillary thyroid carcinoma.
    Sun J, Zhang J, Lu J, Gao J, Lu T, Ren X, Duan H, Liang Z.
    Int J Clin Exp Pathol; 2015 Dec 03; 8(11):15072-8. PubMed ID: 26823846
    [Abstract] [Full Text] [Related]

  • 40. Immunohistochemical detection of the BRAF V600E mutation in papillary thyroid carcinoma. Evaluation against real-time polymerase chain reaction.
    Paja Fano M, Ugalde Olano A, Fuertes Thomas E, Oleaga Alday A.
    Endocrinol Diabetes Nutr; 2017 Feb 03; 64(2):75-81. PubMed ID: 28440781
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.